TC BIOPHARM (HOLDINGS) PLC
Maxim 1, 2 Parklands Way
Holytown, Motherwell ML1 4WR
Scotland, United Kingdom
May 23, 2022
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Ms. Christine Westbrook
Re: TC BioPharm (Holdings) plc
Registration Statement on Form F-1, File No. 333-265159
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Requested Date: May 25, 2022
Requested Time: 5:00 p.m., Eastern time
Ladies and Gentlemen:
TC BioPharm (Holdings) plc (the “Company”) hereby requests that the effective date of the the Company’s registration statement on Form F-1 (File No. 333-265159) be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it will be declared and become effective at 5:00 p.m. Eastern time on May 25, 2022, or as soon thereafter as possible.
Please contact our counsel, Stephen Cohen or Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, at (212) 653-8166 with any questions you may have regarding this request. In addition, the Company requests that you kindly notify our counsel by telephone when this request for acceleration has been granted.
|By:||/s/ Martin Thorp|
|Chief Financial Officer|